chevron_leftBack
As of 5 June 2026, Savior Lifetec Corp. has a market cap of $186.44M USD, ranking #21542 globally and #1006 in Taiwan.
It ranks #1933 in the Healthcare sector, and #699 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$186.44MUSD
5.87B TWD
Enterprise Value
$141.24MUSD
4.44B TWD
Revenue (TTM)
$38.18MUSD
1.2B TWD
EBITDA (TTM)
$8.3MUSD
261.2M TWD
Net Income (TTM)
$17.08MUSD
537.45M TWD
EBITDA Margin
22%
Profit Margin
45%
PE Ratio
11.1
PS Ratio
4.9
PB Ratio
1.6
EV/EBITDA
16.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Chih-Fang Chen
open_in_new
Employees
384
Founded
1993
Website
saviorlifetec.com.tw/en
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.8% | -1.6% | -13% | -6.7% | 10% | -1% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
4167
松瑞製藥股份有限公司
ISIN: TW0004167002
Shares Out.:
Shares Outstanding:
310.444M1
Shares Float:
281.999M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
18.95 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Savior Lifetec Corp.
Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. The company was founded in 1993 and is headquartered in Tainan City, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6446
|
$7.8B
4K%
245.34B TWD
|
48.6
|
|
TWSE: 1795
|
$1.84B
888%
57.95B TWD
|
12.2
|
|
TPEX: 4123
|
$925.15M
396%
29.11B TWD
|
3.4
|
|
TPEX: 6535
|
$808.94M
334%
25.46B TWD
|
-
|
|
TPEX: 4743
|
$788.78M
323%
24.82B TWD
|
-
|
|
TPEX: 4105
|
$583.89M
213%
18.38B TWD
|
11.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
408K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
293K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
193K%
|
97.4
|
|
SIX: RO
|
$323.4B
173K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.25B
155K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$276.26B
148K%
218.9B CHF
|
20.5
|
chevron_leftBack